Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
17.68
+0.59 (3.42%)
At close: Apr 23, 2024, 4:00 PM
18.00
+0.32 (1.81%)
After-hours: Apr 23, 2024, 5:57 PM EDT
Kiniksa Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for KNSA stock have an average target of 28.5, with a low estimate of 25 and a high estimate of 32. The average target predicts an increase of 61.20% from the current stock price of 17.68.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 2, 2024.
Analyst Ratings
The average analyst rating for KNSA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $23 → $25 | Buy | Maintains | $23 → $25 | +41.40% | Jan 2, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $22 → $32 | Strong Buy | Maintains | $22 → $32 | +81.00% | Jul 26, 2023 |
| JP Morgan | JP Morgan | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +13.12% | Mar 9, 2023 |
| B of A Securities | B of A Securities | Strong Buy Maintains $37 → $34 | Strong Buy | Maintains | $37 → $34 | +92.31% | Dec 29, 2021 |
| B of A Securities | B of A Securities | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Apr 1, 2020 |
Financial Forecast
Revenue This Year
390.59M
from 270.26M
Increased by 44.52%
Revenue Next Year
522.63M
from 390.59M
Increased by 33.81%
EPS This Year
-0.17
from 0.20
EPS Next Year
0.05
from -0.17
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 443.5M | 633.9M | 695.2M | 737.1M | 707.7M |
| Avg | 390.6M | 522.6M | 628.7M | 635.5M | 543.9M |
| Low | 359.0M | 436.1M | 541.9M | 533.1M | 384.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 64.1% | 62.3% | 33.0% | 17.2% | 11.4% |
| Avg | 44.5% | 33.8% | 20.3% | 1.1% | -14.4% |
| Low | 32.8% | 11.7% | 3.7% | -15.2% | -39.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 0.79 | 1.08 | 0.42 | -0.11 |
| Avg | -0.17 | 0.05 | 0.09 | -0.10 |
| Low | -0.66 | -0.64 | -0.23 | -0.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 293.8% | - | 782.3% | - |
| Avg | - | - | 82.1% | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.